This Semaglutide pre-filled pen injection is contraindicated in individuals with a personal or family history of Medullary Thyroid Carcinoma (MTC), Multiple Endocrine Neoplasia syndrome type 2 (MEN 2), Pancreatitis, severe gastrointestinal problems, or Diabetic Ketoacidosis
Its important to follow any aftercare instructions provided by your healthcare provider and to monitor how you feel over time
For a platform that otherwise shares Belles infrastructure, named drug allergy screen, and named interaction list, the absence of MTC and MEN-2 is a notable gap the FDA black-box warning on GLP-1 medications names both conditions specifically
GHK-Cu Peptide & Barrier Integrity (Preclinical Research) In a mouse model of DSS-induced ulcerative colitis, researchers observed that GHK-Cu influenced cellular signaling pathways related to barrier integrity, including: Tight junction protein expression SIRT1/STAT3 signaling pathways While this study was preclinical and not cosmetic-focused, it reinforced something researchers have long suspected: GHK-Cu interacts with fundamental cellular repair processes, not just surface-level skin processes [1]